@gurujosh.bsky.social
Infectious Diseases physician, clinical researcher - clinical trials, SAB, PJI, sepsis, viral hep. CI of SNAP and ROADMAP trials. Runner, Novocastrian, Dad (and thus Dad jokes ++), Chocoholic #IDSky #SNAPtrial
@angelahuttner.bsky.socialReposted by @gurujosh.bsky.socialThis one just makes me smile
Henning recites Danish poetry 🫶
We learn POET 1 started with a case series, n=12 (every piece of evidence matters!)
The two guests are so humble, thoughtful and curious
Have a bit of host-envy, @gurujosh.bsky.social & @dremilymcd.bsky.social!!
@steventong.bsky.socialReposted by @gurujosh.bsky.socialThe next Clarity commentary. On the SNAP trial. Neither I nor @gurujosh.bsky.social had anything to do with this commentary (deliberately).
Conclusions though are in line with my interpretation of the data. i.e., use cefazolin for MSSA bacteremia.
@angelahuttner.bsky.social @cmicomms.bsky.social
@gurujosh.bsky.socialDavid Paterson at #ESCMIDGlobal2026 Highlights important issue of generic versus brand name meropenem – previous work has suggested chemical differences, harder to dissolve and even higher mortality with generic preparations
